P.A.W. CAPITAL CORP – Eiger BioPharmaceuticals, Inc. Transaction History
P.A.W. CAPITAL CORP portfolio value:
$4.06M
portfolio value
P.A.W. CAPITAL CORP quarter portfolio value change:
+19.52%
quarter
Eiger BioPharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 664K | $7.53 | 540K | |
| Q2 2022 | share | 0.00% | 0 shares | -1.08M | $6.3 | 540K | |
| Q1 2022 | share | Increase | +8.00% | 40K shares | 1.88M | $8.3 | 540K |
| Q4 2021 | share | Increase | +25.00% | 100K shares | -77K | $5.21 | 500K |
| Q3 2021 | share | 0.00% | 0 shares | -736K | $6.68 | 400K | |
| Q2 2021 | share | Increase | +5.26% | 20K shares | 45K | $8.52 | 400K |
| Q1 2021 | share | Decrease | -5.00% | -20K shares | -1.55M | $8.85 | 380K |
| Q4 2020 | share | Increase | +11.11% | 40K shares | 1.98M | $12.29 | 400K |
| Q3 2020 | share | Increase | +20.00% | 60K shares | 50K | $8.14 | 360K |
| Q2 2020 | share | Decrease | -16.67% | -60K shares | 432K | $9.6 | 300K |
| Q1 2020 | share | Increase | +150.00% | 216K shares | 302K | $6.8 | 360K |
| Q4 2019 | share | Decrease | -28.00% | -56K shares | 96K | $14.9 | 144K |
| Q3 2019 | share | 0.00% | 0 shares | -70K | $10.25 | 200K | |
| Q2 2019 | share | Increase | +5.26% | 10K shares | -536K | $10.6 | 200K |
| Q1 2019 | share | Decrease | -13.64% | -30K shares | 421K | $13.98 | 190K |
| Q4 2018 | share | Increase | +528.57% | 185K shares | 1.81M | $10.16 | 220K |
| Q3 2018 | share | Decrease | -61.11% | -55K shares | -678K | $12 | 35K |
| Q2 2018 | share | Decrease | -33.33% | -45K shares | -232K | $12.2 | 90K |
| Q1 2018 | share | Increase | +35.00% | 35K shares | -65K | $9.85 | 135K |
| Q4 2017 | share | Increase | +25.00% | 20K shares | 515K | $13.95 | 100K |
| Q3 2017 | share | Increase | 0.00% | 80K shares | 880K | $11 | 80K |